Ledger.Open graph →
SEC Form D · filed April 16, 2013

BEAT BioTherapeutics Corp

Offering
$2.5M
Sold
$2.4M
Exemption
—
Industry
Biotechnology
Location
BELLEVUE, WA
Type
—

People & firms on this filing (5)

Michael Kranda · Bellevue, WAExec · DirectorMichael Kranda · Bellevue, WAExec · DirectorGreg Mahairas, Ph.D · Bellevue, WAExec · DirectorJim Leggett · Bellevue, WADirectorCraig Tall · Mercer Island, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗